Found: 4
Select item for more details and to access through your institution.
Selinexor for the treatment of patients with relapsed or refractory multiple myeloma.
- Published in:
- Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 3, p. 535, doi. 10.1177/10781552241235902
- By:
- Publication type:
- Article
Use of venetoclax in t(11;14) positive relapsed/refractory multiple myeloma: A systematic review.
- Published in:
- Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 3, p. 552, doi. 10.1177/10781552231218999
- By:
- Publication type:
- Article
Treatment of eculizumab refractory paroxysmal nocturnal hemoglobinuria: A systematic review about current treatment options and future direction.
- Published in:
- SAGE Open Medicine, 2023, p. 1, doi. 10.1177/20503121231181267
- By:
- Publication type:
- Article
A systematic review on the available treatment modalities for Bacillus Calmette–Guérin-unresponsive carcinoma in situ and tumors in patients who are ineligible for or decline radical cystectomy.
- Published in:
- SAGE Open Medicine, 2023, p. 1, doi. 10.1177/20503121231160408
- By:
- Publication type:
- Article